90 research outputs found

    Казахстан на страницах Туркестанского сборника

    Get PDF
    Presently most adolescent anxiety disorder screening instruments make their determination of running a high risk for an anxiety disorder on the basis of a cut-off score measured by a single screening which can lead to false positives. Therefore, the goal of this study is to examine whether a repeated administration of the SCARED screening instrument for DSM-5 anxiety disorder symptoms could help in the detection of true positives while also avoiding false positives. Participants were 923 early adolescents from the general community. The adolescents’ ages at the first annual screening ranged from 10 to 15 with an average of 12.5 years. In a prospective five-year longitudinal design, the adolescents completed the SCARED screening instrument for anxiety disorder symptoms on a yearly basis. To detect true positives and avoid false positives, the data were analyzed with Receiver Operating Characteristics (ROC) cut-off score analyses. ROC cut-off score analyses revealed that the sensitivity and specificity of high risk were greatly improved for repeated screenings above those of a single screening. The findings of this study demonstrate that a screening instrument (such as the SCARED) should be administered not just once but several times in order to better determine true positives and avoid false positives

    Ontwikkelingstrajecten van angstsymptomen: Een vijfjarig prospectief onderzoek onder adolescenten in de algemene populatie

    Get PDF
    Achtergrond: Het relatief recente gebruik van moderne statistische analysemethoden zoals een latent groeimodel (lgm) maakt het mogelijk om verschillen in individuele ontwikkelingstrajecten over tijd te bestuderen. doel Prospectief en longitudinaal onderzoeken van de ontwikkelingstrajecten van angstsymptomen over een periode van vijf jaar in een grote steekproef (n = 1318) uit de algemene adolescentenpopulatie. Methode: Er werd onderscheid gemaakt tussen een cohort jongeren in de vroege adolescentie (gemiddeld 12 jaar oud tijdens de eerste meting) en in de midden adolescentie (gemiddeld 16 jaar oud tijdens de eerste meting). Leeftijds- en sekseverschillen in de ontwikkelingstrajecten van angstsymptomen werden onderzocht met lgm. resultaten Uit de analyses bleek dat de symptomen van de paniekstoornis, schoolangst en separatieangst voor alle adolescent

    On the elasto-viscoplastic behavior of the Ti5553 alloy

    Get PDF
    The elastoviscoplastic behavior of the Ti5553 alloy is characterized and compared to the classical Ti–6Al–4V alloy. The true stress–strain curves are determined based on tensile tests performed under different strain rates at room temperature and at 1501C, from which the elastic constants and the parameters of a Norton–Hoff viscoplastic model are identified. The strength of the Ti5553 alloy is 20–40% higher than the strength of the Ti–6Al–4V alloy. The Ti5553 alloy constitutes thus a promising candidate for advanced structural applications. In view of modeling structural applications of forming operations, the elastic and plastic initial anisotropy of the two alloys is investigated by combining compression on cylinders with elliptical sections, uniaxial tensile tests in different material directions, plane strain and shear tests. The initial anisotropy of the different alloys is very weak which justifies the modeling of the mechanical behavior with an isotropic yield surface. The identified elastoviscoplastic model is validated by comparing experimental results with FE predictions both on cylindrical notched specimens subjected to tensile tests and onflat specimens subjected to plane strain conditions

    ADP Ribosylation Factor Like 2 (Arl2) Regulates Breast Tumor Aggressivity in Immunodeficient Mice

    Get PDF
    We have previously reported that ADP ribosylation factor like 2 (Arl2), a small GTPase, content influences microtubule dynamics and cell cycle distribution in breast tumor cells, as well as the degree and distribution of phosphorylated P53. Here we show, in two different human breast adenocarcinoma models, that Arl2 content has a major impact on breast tumor cell aggressivity both in vitro and in vivo. Cells with reduced content of Arl2 displayed reduced contact inhibition, increased clonogenic or cluster formation as well as a proliferative advantage over control cells in an in vitro competition assay. These cells also caused larger tumors in SCID mice, a phenotype which was mimicked by the in vivo administration of siRNA directed against Arl2. Cells with increased Arl2 content displayed reduced aggressivity, both in vitro and in vivo, with enhanced necrosis and were also found to contain increased PP2A phosphatase activity. A rt-PCR analysis of fresh human tumor breast samples suggested that low Arl2 expression was associated with larger tumor size and greater risk of lymph node involvement at diagnosis. These data underline the role of Arl2, a small GTPase, as an important regulator of breast tumor cell aggressivity, both in vitro and in vivo

    Report on SHAFE policies, strategies and funding

    Full text link
    The objective of Working Group (WG) 4 of the COST Action NET4Age-Friendly is to examine existing policies, advocacy, and funding opportunities and to build up relations with policy makers and funding organisations. Also, to synthesize and improve existing knowledge and models to develop from effective business and evaluation models, as well as to guarantee quality and education, proper dissemination and ensure the future of the Action. The Working Group further aims to enable capacity building to improve interdisciplinary participation, to promote knowledge exchange and to foster a cross-European interdisciplinary research capacity, to improve cooperation and co-creation with cross-sectors stakeholders and to introduce and educate students SHAFE implementation and sustainability (CB01, CB03, CB04, CB05). To enable the achievement of the objectives of Working Group 4, the Leader of the Working Group, the Chair and Vice-Chair, in close cooperation with the Science Communication Coordinator, developed a template (see annex 1) to map the current state of SHAFE policies, funding opportunities and networking in the COST member countries of the Action. On invitation, the Working Group lead received contributions from 37 countries, in a total of 85 Action members. The contributions provide an overview of the diversity of SHAFE policies and opportunities in Europe and beyond. These were not edited or revised and are a result of the main areas of expertise and knowledge of the contributors; thus, gaps in areas or content are possible and these shall be further explored in the following works and reports of this WG. But this preliminary mapping is of huge importance to proceed with the WG activities. In the following chapters, an introduction on the need of SHAFE policies is presented, followed by a summary of the main approaches to be pursued for the next period of work. The deliverable finishes with the opportunities of capacity building, networking and funding that will be relevant to undertake within the frame of Working Group 4 and the total COST Action. The total of country contributions is presented in the annex of this deliverable
    corecore